Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,960,527
+$233,440 QoQ
Shares Held
7,791
-1.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#1,974
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 32%
Shared 0%
None 68%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KELLY LAWRENCE W & ASSOCIATES INC/CA holds $15,835,572 across 7 Drug Manufacturers - General names. ABBV ranks #2 (12.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
47,610 | $12,091,511 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
7,791 | $1,960,527 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
6,044 | $763,598 | |
| 4 | AMGN |
Amgen Inc
|
1,398 | $506,243 | |
| 5 | LLY |
ELI LILLY & Co
|
227 | $272,270 | |
| 6 | PFE |
Pfizer Inc
|
9,130 | $219,850 | |
| 7 | NVO |
Novo Nordisk A S
|
450 | $21,573 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,960,527 | 7,791 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,727,087 | 7,941 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,046,584 | 8,957 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,078,534 | 8,977 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,770,257 | 9,537 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,998,192 | 9,537 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,748,034 | 9,837 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,925,627 | 9,751 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,712,798 | 9,986 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,973,235 | 10,836 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,697,076 | 10,951 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,632,355 | 10,951 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,488,900 | 11,051 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,106,551 | 13,218 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,136,160 | 13,218 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,773,987 | 13,218 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $2,062,758 | 13,468 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,183,297 | 13,468 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,868,926 | 13,803 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,568,968 | 14,545 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,638,348 | 14,545 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,552,415 | 14,345 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $480,567 | 4,485 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,414,140 | 16,145 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,585,116 | 16,145 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,230,087 | 16,145 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||